1. India Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - General
Sanofi India Limited

Sanofi India Limited

SANOFI.BO
Sanofi India LimitedIN flagBombay Stock Exchange
3,446.85
INR
+18.85
- -
79.36BMarket Cap

Total Valuation

Sanofi India Limited carries a market capitalization of 79.36B, placing it among publicly traded companies globally. Its enterprise value stands at 143.92B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap79.36B
Enterprise Value143.92B

Share Statistics

Sanofi India Limited currently has 23.03M shares outstanding.

Shares Outstanding23.03M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

Sanofi India Limited trades at a trailing price-to-earnings ratio of 40.51. The price-to-sales ratio is 7.41, and the price-to-book ratio stands at 638.43.

PE Ratio40.51
PS Ratio7.41
PB Ratio638.43
P/TBV Ratio18.80
P/FCF RatioN/A
P/OCF RatioN/A

Enterprise Valuation

On an enterprise value basis, Sanofi India Limited trades at an EV/EBITDA multiple of 30.78 and an EV/FCF ratio of 13,080.41. The EV/Sales ratio of 7.26 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 30.78 provides insight into valuation relative to core operating earnings.

EV / Sales7.26
EV / EBITDA30.78
EV / EBIT30.78
EV / FCF13,080.41

Financial Position

Sanofi India Limited maintains a current ratio of 1.85, meaning it holds 1.9x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 2.67, indicating elevated leverage, while an interest coverage ratio of 311.67 demonstrates strong ability to service its debt obligations.

Current Ratio1.85
Quick Ratio0.74
Debt / Equity2.67
Debt / EBITDA0.04
Interest Coverage311.67

Financial Efficiency

Sanofi India Limited posts a return on equity of 1,576.09 and a return on invested capital of 39.97.

Return on Equity (ROE)1,576.09
Return on Assets (ROA)27.89
Return on Invested Capital (ROIC)39.97
Return on Capital Employed (ROCE)817.08
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover3.05

Taxes

Over the trailing twelve months, Sanofi India Limited has paid 1.32B in income taxes, reflecting an effective tax rate of 26.65.

Income Tax1.32B
Effective Tax Rate26.65

Stock Price Statistics

Sanofi India Limited's stock has declined approximately -42.53478% over the past 52 weeks. The 50-day moving average sits at 3,288.85, while the 200-day moving average is 3,939.34.

Beta (5Y)N/A
52-Week Price Change-42.53478%
50-Day Moving Average3,288.85
200-Day Moving Average3,939.34
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Sanofi India Limited generated 19.81B in revenue and converted that into 3.63B in net income, yielding earnings per share of 157.40. EBITDA reached 4.68B, while operating income came in at 4.68B.

Revenue19.81B
Gross Profit10.22B
Operating Income4.68B
Pretax Income4.94B
Net Income3.63B
EBITDA4.68B
EBIT4.68B
Earnings Per Share (EPS)157.40

Balance Sheet

Sanofi India Limited holds 3.13B in cash and equivalents against 209.00M in total debt, resulting in a net debt position of -2.95B. Total book value stands at 230.00M, with working capital of 3.58B providing operational flexibility.

Cash & Cash Equivalents3.13B
Total Debt209.00M
Net Debt-2.95B
Equity (Book Value)230.00M
Book Value Per Share9.99
Working Capital3.58B

Margins

Sanofi India Limited operates with a gross margin of 51.59, reflecting its pricing power and cost economics. The operating margin of 23.60 and net profit margin of 18.30 provide insight into operational efficiency.

Gross Margin51.59
Operating Margin23.60
Pretax Margin24.95
Profit Margin18.30
EBITDA Margin23.60

Scores

Sanofi India Limited posts an Altman Z-Score of 22.48, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score22.48